JAMA Oncology Author Interviews podcast

Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in ERBB2-Positive Breast Cancer

0:00
13:01
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Flere episoder fra "JAMA Oncology Author Interviews"